Pancreatic Neuroendocrine Tumor has active NIH research funding with 14 funded grants totaling $12.1M.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Pancreatic Neuroendocrine Tumor. Strongest funded area: Basic Science. Largest gap: Biomarker / Diagnostics.
20 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for pancreatic neuroendocrine tumor. Existing research activity suggests this may be a viable area for grant applications.
These grants mention Pancreatic Neuroendocrine Tumor as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Track funding opportunities for Pancreatic Neuroendocrine Tumor.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.